Previous studies integrated tumour location, tumour size, CEA, and radiomics features to construct a clinical-radiomics model for PDAC staging, achieving AUCs of 0.92 in the training cohort and 0.83 in the test cohort [33]. The gene discussed is CEACAM5; the disease is neoplasm.